Predicting 30-day mortality after surgery for metastatic disease of the spine: the H


Journal

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society
ISSN: 1432-0932
Titre abrégé: Eur Spine J
Pays: Germany
ID NLM: 9301980

Informations de publication

Date de publication:
Jul 2023
Historique:
received: 02 12 2022
accepted: 06 04 2023
revised: 14 03 2023
medline: 26 6 2023
pubmed: 15 5 2023
entrez: 15 5 2023
Statut: ppublish

Résumé

Scoring systems for metastatic spine disease focus on predicting long- to medium-term mortality or a combination of perioperative morbidity and mortality. However, accurate prediction of perioperative mortality alone may be the most important factor when considering surgical intervention. We aimed to develop and evaluate a new tool, the H Using the National Surgical Quality Improvement Program database, we identified 1195 adults who underwent surgery for metastatic spine disease from 2010 to 2018. Incidence of 30-day mortality was 8.7% (n = 104). Independent predictors of 30-day mortality were used to derive the H Predicted 30-day mortality was 1.8% for an H The H Prognostic level III.

Identifiants

pubmed: 37186159
doi: 10.1007/s00586-023-07713-5
pii: 10.1007/s00586-023-07713-5
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2513-2520

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Maccauro G, Spinelli MS, Mauro S et al (2011) Physiopathology of spine metastasis. Int J Surg Oncol 2011:107969. https://doi.org/10.1155/2011/107969
doi: 10.1155/2011/107969 pubmed: 22312491 pmcid: 3265280
Klimo P, Thompson CJ, Kestle JRW, Schmidt MH (2005) A meta-analysis of surgery versus conventional radiotherapy for the treatment of metastatic spinal epidural disease. Neuro Oncol 7:64–76. https://doi.org/10.1215/S1152851704000262
doi: 10.1215/S1152851704000262 pubmed: 15701283 pmcid: 1871618
Lenz M, Freid JR (1931) Metastases to the skeleton, brain and spinal cord from cancer of the breast and the effect of radiotherapy. Ann Surg 93:278–293. https://doi.org/10.1097/00000658-193101000-00036
doi: 10.1097/00000658-193101000-00036 pubmed: 17866472 pmcid: 1398734
Wong DA, Fornasier VL, MacNab I (1990) Spinal metastases: the obvious, the occult, and the impostors. Spine (Phila Pa 1976) 15:1–4
doi: 10.1097/00007632-199001000-00001 pubmed: 2326692
Ghori AK, Leonard DA, Schoenfeld AJ et al (2015) Modeling 1-year survival after surgery on the metastatic spine. Spine J 15:2345–2350. https://doi.org/10.1016/j.spinee.2015.06.061
doi: 10.1016/j.spinee.2015.06.061 pubmed: 26160329
De la Garza RR, Goodwin CR, Jain A et al (2016) Development of a metastatic spinal tumor frailty index (MSTFI) using a nationwide database and its association with inpatient morbidity, mortality, and length of stay after spine surgery. World Neurosurg 95:548-555.e4. https://doi.org/10.1016/j.wneu.2016.08.029
doi: 10.1016/j.wneu.2016.08.029
Hersh EH, Sarkiss CA, Ladner TR et al (2018) Perioperative risk factors for thirty-day morbidity and mortality in the resection of extradural thoracic spine tumors. World Neurosurg 120:e950–e956. https://doi.org/10.1016/j.wneu.2018.08.195
doi: 10.1016/j.wneu.2018.08.195 pubmed: 30189310
Lakomkin N, Zuckerman SL, Stannard B et al (2019) Preoperative risk stratification in spine tumor surgery: a comparison of the modified Charlson Index, Frailty Index, and ASA score. Spine (Phila Pa 1976) 44:E782–E787. https://doi.org/10.1097/BRS.0000000000002970
doi: 10.1097/BRS.0000000000002970 pubmed: 31205174
Paulino Pereira NR, Janssen SJ, van Dijk E et al (2016) Development of a prognostic survival algorithm for patients with metastatic spine disease. J Bone Joint Surg Am 98:1767–1776. https://doi.org/10.2106/JBJS.15.00975
doi: 10.2106/JBJS.15.00975 pubmed: 27807108
Quraishi NA, Manoharan SR, Arealis G et al (2013) Accuracy of the revised Tokuhashi score in predicting survival in patients with metastatic spinal cord compression (MSCC). Eur Spine J 22(Suppl 1):S21-26. https://doi.org/10.1007/s00586-012-2649-5
doi: 10.1007/s00586-012-2649-5 pubmed: 23328875
Sarkiss CA, Hersh EH, Ladner TR et al (2018) Risk factors for thirty-day morbidity and mortality in extradural lumbar spine tumor resection. World Neurosurg 114:e1101–e1106. https://doi.org/10.1016/j.wneu.2018.03.155
doi: 10.1016/j.wneu.2018.03.155 pubmed: 29609084
Tabouret E, Cauvin C, Fuentes S et al (2015) Reassessment of scoring systems and prognostic factors for metastatic spinal cord compression. Spine J 15:944–950. https://doi.org/10.1016/j.spinee.2013.06.036
doi: 10.1016/j.spinee.2013.06.036 pubmed: 24120144
Schoenfeld AJ, Le HV, Marjoua Y et al (2016) Assessing the utility of a clinical prediction score regarding 30-day morbidity and mortality following metastatic spinal surgery: the New England Spinal Metastasis Score (NESMS). Spine J 16:482–490. https://doi.org/10.1016/j.spinee.2015.09.043
doi: 10.1016/j.spinee.2015.09.043 pubmed: 26409416
Lape EC, Katz JN, Blucher JA et al (2020) Patient experiences of decision-making in the treatment of spinal metastases: a qualitative study. Spine J 20:905–914. https://doi.org/10.1016/j.spinee.2019.12.018
doi: 10.1016/j.spinee.2019.12.018 pubmed: 31899375
Shiloach M, Frencher SK, Steeger JE et al (2010) Toward robust information: data quality and inter-rater reliability in the American College of Surgeons National Surgical Quality Improvement Program. J Am Coll Surg 210:6–16. https://doi.org/10.1016/j.jamcollsurg.2009.09.031
doi: 10.1016/j.jamcollsurg.2009.09.031 pubmed: 20123325
CPT code lookup, CPT codes and search. In: Codify by AAPC. https://www.aapc.com/codes/cpt-codes-range . Accessed 14 Oct 2021
ICD-10 Codes: lookup and conversion. https://icdcodelookup.com/icd-10/codes . Accessed 14 Oct 2021
Moons KGM, Altman DG, Reitsma JB et al (2015) Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med 162:W1-73. https://doi.org/10.7326/M14-0698
doi: 10.7326/M14-0698 pubmed: 25560730
Steyerberg EW, Harrell FE, Borsboom GJ et al (2001) Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 54:774–781. https://doi.org/10.1016/s0895-4356(01)00341-9
doi: 10.1016/s0895-4356(01)00341-9 pubmed: 11470385
Kumar N, Thomas AC, Ramos MRD et al (2021) Readmission-free survival analysis in metastatic spine tumour surgical patients: a novel concept. Ann Surg Oncol 28:2474–2482. https://doi.org/10.1245/s10434-020-09404-7
doi: 10.1245/s10434-020-09404-7 pubmed: 33393052
Tokuhashi Y, Uei H, Oshima M, Ajiro Y (2014) Scoring system for prediction of metastatic spine tumor prognosis. World J Orthop 5:262–271. https://doi.org/10.5312/wjo.v5.i3.262
doi: 10.5312/wjo.v5.i3.262 pubmed: 25035829 pmcid: 4095019
Ragel BT, Mendez GA, Reddington J et al (2017) Life expectancy and metastatic spine scoring systems: an academic institutional experience. Clin Spine Surg 30:335–342. https://doi.org/10.1097/BSD.0000000000000154
doi: 10.1097/BSD.0000000000000154 pubmed: 28937454
Laufer I, Rubin DG, Lis E et al (2013) The NOMS framework: approach to the treatment of spinal metastatic tumors. Oncologist 18:744–751. https://doi.org/10.1634/theoncologist.2012-0293
doi: 10.1634/theoncologist.2012-0293 pubmed: 23709750 pmcid: 4063402
Schoenfeld AJ, Leonard DA, Saadat E et al (2016) Predictors of 30- and 90-day survival following surgical intervention for spinal metastases: a prognostic study conducted at four academic centers. Spine (Phila Pa 1976) 41:E503-509. https://doi.org/10.1097/BRS.0000000000001273
doi: 10.1097/BRS.0000000000001273 pubmed: 27064339

Auteurs

Farah N Musharbash (FN)

Department of Orthopaedic Surgery, The Johns Hopkins Hospital, Baltimore, MD, USA.

Jawad M Khalifeh (JM)

Department of Neurosurgery, The Johns Hopkins University, 601 North Caroline Street, Suite 5223, Baltimore, MD, 21287, USA.

Micheal Raad (M)

Department of Orthopaedic Surgery, The Johns Hopkins Hospital, Baltimore, MD, USA.

Varun Puvanesarajah (V)

Department of Orthopaedic Surgery, The Johns Hopkins Hospital, Baltimore, MD, USA.

Sang H Lee (SH)

Department of Orthopaedic Surgery, The Johns Hopkins Hospital, Baltimore, MD, USA.

Brian J Neuman (BJ)

Department of Orthopaedic Surgery, The Johns Hopkins Hospital, Baltimore, MD, USA.

Khaled M Kebaish (KM)

Department of Orthopaedic Surgery, The Johns Hopkins Hospital, Baltimore, MD, USA. editorialservices@jhmi.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH